Medable, a developer of a cloud-based platform, is designed to offer efficient therapies to patients globally. The platform comprises modules like back-end, analytics, collaboration, compliance, and research survey, all tailored to address the stringent compliance, interoperability, and privacy issues in the healthcare sector. This enables healthcare professionals to simplify digital trials and allow broad patient access and results.

Investors include:

Further Key Investors:

ACVC Partners, Emerson Collective, National Cancer Institute, Launchpad Digital Health, Sapphire Ventures, PROOF, GSR Ventures China, Blackstone, Business Association of Stanford Entrepreneurial Students, National Institutes of Health, U.S. Department of Health and Human Services, Obvious Ventures, Western Technology Investment, Springboard Enterprises, Loren McFarland, HealthX Ventures, Steve Wang, Texas Medical Center, Pharmaceutical Product Development, Streamlined Ventures, Connectivity Ventures Fund, Anula Jayasuriya, North Sky Capital, Ullas Naik.

Looking to sell Medable Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you